Literature DB >> 26824229

Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.

Wanshuai Li, Yong Wang, Qi Zhang, Lili Tang, Xiaoping Liu, Yunhua Dai, Liang Xiao, Shuguang Huang, Lu Chen, Zhongmin Guo, Kai Yuan, Jim Lu.   

Abstract

Entities:  

Year:  2016        PMID： 26824229      PMCID： PMC4732608          DOI： 10.1371/journal.pone.0148589

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The authors are listed out of order. Please view the correct author order and affiliations here: Wanshuai Li2, Yong Wang1, Qi Zhang2, Lili Tang2, Xiaoping Liu2, Yunhua Dai2, Liang Xiao2, Shuguang Huang2, Lu Chen2, Zhongmin Guo2,3, Jim Lu2,3, Kai Yuan1 1 The Department of Cardiothoracic Surgery, No. 2 People's Hospital of Changzhou, 29 Xinglong Xiang, Changzhou, Jiangsu, 213004, China, 2 Changzhou GoPath Diagnostic Laboratory Co. Ltd, 801 Changwuzhong Road, Changzhou, Jiangsu, 213164, China, 3 GoPath Laboratories LLC, 1351 Barclay Blvd, Buffalo Grove, Illinois, 60089, United States of America
  1 in total

1.  MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.

Authors:  Wanshuai Li; Yong Wang; Qi Zhang; Lili Tang; Xiaoping Liu; Yunhua Dai; Liang Xiao; Shuguang Huang; Lu Chen; Zhongmin Guo; Jim Lu; Kai Yuan
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240
  1 in total
  2 in total

1.  miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer.

Authors:  Sunfeng Yu; Shuang Geng; Yi Hu
Journal:  Oncol Lett       Date:  2018-06-29       Impact factor: 2.967

2.  Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xiaoying Li; Baosen Zhou
Journal:  Biomed Res Int       Date:  2018-06-28       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.